On January 18, 2024, the Board of Directors (the ?Board?) of The AES Corporation (the ?Company?) approved the appointment of Mr. Inderpal S. Bhandari to serve as a director on the Board, effective January 18, 2024 . Mr. Bhandari will serve for a term expiring on the date of the Company?s 2024 Annual Meeting of Stockholders and until his successor has been duly elected and qualified, or until his earlier resignation or removal from office. Mr. Bhandari has been appointed to serve as a member of the Company?s Innovation and Technology Committee.

Mr. Bhandari has served as Global Chief Data Officer of International Business Machine Corporation (?IBM?), a multinational technology corporation, from December 2015 to July 2023, where he led IBM?s global data strategy. He also served as the CDataO Program Advisory Board Chair and Strategic Advisor at Carnegie Mellon University, a private global research university, since February 2021. Prior to IBM, he spent more than 20 years working in the healthcare industry including at Cambia Health Solutions, a regional health plan provider and healthcare investment firm, as Senior Vice President and Chief Data Officer from 2014 to 2015; Express Scripts Inc., a pharmacy benefit management and pharmacy services company, as Chief Data Officer and Vice President, Knowledge Solutions from 2012 to 2014; and Medco Health Solutions Inc., a pharmacy benefit management and pharmacy services company, as Chief Data Officer and Vice President, Health Data and Analytics from 2006 to 2012.